Hidden Picks (Sponsored)
How would it feel to double your money by this time next year?
From thousands of stocks, only 5 have emerged with the best chance to gain +100% or more in the months ahead.
You can see all five of these tickers — absolutely free.
Just download the newly released 5 Stocks Set to Double special report from Zacks.
While we can’t guarantee future performance, previous editions of this report have delivered gains of +175%, +498%, and even +673¹.
The newest picks could be just as profitable.
Act fast — this opportunity ends at MIDNIGHT TONIGHT.
Download the report now, absolutely free
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
A once high-flying biotech has been left for dead after halting programs and cutting staff. But with a game-changing therapy approaching key milestones and fresh institutional backing, the setup could be shifting. Find out why investors are watching closely today.
In partnership with
This One’s for People In-the-Know
You’re informed because you’re reading a newsletter… that’s why you’re getting the first crack at this opportunity.
The Flyover is growing faster than legacy giants like CNN ever dreamed (their active daily audience is 5X bigger than CNN’s primetime viewers).
With 2.5 million loyal readers and explosive 611% revenue growth, The Flyover is proving there’s a better way to deliver honest news directly to Americans without corporate spin or algorithm games.
There are still 70 million+ readers out there looking for something more trustworthy. Don’t miss this rare opportunity to back The Flyover as they expand into new states, daily podcasts, and SMS platforms to meet that demand.
This is a paid advertisement for The Flyover’s Regulation CF offering. Please read the offering circular at https://invest.jointheflyover.com/.
Futures 📈
Want to make sure you never miss a pre-market alert?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.
Email’s great. Texts are faster.
You’ll be first in line when the market starts moving.
What to Watch
Premarket Earnings:
PDD Holdings Inc. [PDD]
NAPCO Security Technologies, Inc. [NSSC]
StealthGas, Inc. [GASS]
Aftermarket Earnings:
Heico Corporation [HEI]
Semtech Corporation [SMTC]
FS Credit Opportunities Corp. [FSCO]
Senstar Technologies Corporation [SNT]
Economic Reports:
New home sales [July]: 10:00 am
Dallas Fed President Lorie Logan speaks: 3:15 pm
New York Fed President John Williams speaks: 7:15 pm
Technology
Verint Systems Pops on $2B Takeover Talk
Verint Systems (VRNT) surged in premarket trading after reports surfaced that Thoma Bravo is preparing a $2 billion buyout of the call center software company.
The private equity firm, which manages over $180 billion in assets, has been one of the most aggressive consolidators in the software space, targeting companies with sticky recurring revenues and large enterprise client lists.
For Verint, whose stock has fallen nearly 40% in the past year, the timing could not be better.
The company is best known for its customer engagement automation tools, which count Microsoft, Google, and Lyft among high-profile users. But slowing growth and execution hiccups left it trading near multi-year lows, making it a prime target for a take-private bid.
Friday’s 6% gain was followed by a sharp 13% premarket rally as traders positioned ahead of what could be a formal announcement this week.
If the deal closes near the rumored valuation, it would mark a hefty premium to Verint’s $1.2 billion market cap and potentially spark competitive interest from other private equity buyers.
For active investors, that sets up a simple trade: follow momentum as headlines roll out, while keeping in mind that deal talks can collapse just as quickly.
Traders should be watching whether VRNT approaches the implied buyout price. Confirmation could mean another leg higher, while uncertainty may bring volatility. Either way, Verint is squarely on the radar this morning.
Education
McGraw Hill Earns Fresh ‘Strong Buy’ Call
McGraw Hill (MH) jumped nearly 6% in premarket trading after Baird analysts upgraded the stock to Strong Buy, citing an undervalued path to growth.
The call follows a wave of positive initiations in recent weeks, with Morgan Stanley, William Blair, Rothschild & Co, and Macquarie all publishing Buy or Outperform ratings and price targets ranging between $19 and $28. That represents significant upside from Monday’s close at $14.60.
The publisher has spent the past several years transforming from a traditional textbook business into a digital-first platform. Its adaptive learning products and data-driven courseware are designed to personalize the student experience while giving educators better tools to track progress.
With AI integration expected in the next product cycle, McGraw Hill is positioning itself for steady, tech-enabled growth in a sector hungry for modernization.
What’s compelling for investors is the valuation disconnect. Shares have slid 14% this year even as revenue and margins have stabilized.
Analysts argue the stock is trading below intrinsic value, setting up a possible rerating as institutional coverage deepens and earnings visibility improves.
With education tech drawing fresh attention ahead of back-to-school season, sentiment could shift quickly. If momentum carries through, a retest of the $17.25 high looks realistic near-term, with longer-term analyst targets pointing toward the $20–28 range.
Lotto Trade Power (Sponsored)
What if you knew EXACTLY what to look for in a trade before you took it?
Better yet...
What if you also didn’t have to risk a fortune to target 100%, 300% or even 1,000% within days... or even HOURS?
Over the past few years, Millionaire Trader Nate Bear has been using a special $2 (or less) trade to collect MASSIVE returns, like....
$65 into $800 in 2 days...
$246 into $903 within hours...
$305 into $1,205 overnight...
$1,250 into $11,540 overnight...
Or even $3,650 into $14,677 overnight...
He calls them “lotto trades”...
And they’re a big reason why he was able to turn $37k into $2.7 Million in just 4 years.
And on Wednesday, August 27th @ 2 P.M. ET during his first-ever 10X Lotto Trade Summit...
He's going LIVE to walk you through EXACTLY what he looks for when targeting these lotto trades...
And he’s even going to place a live trade or two to give you an opportunity to see just how lucrative these trades can be.
Click here to reserve your FREE spot.
Biotech
Intellia Therapeutics Gains Ark Support Amid Streamlined Focus
Intellia Therapeutics (NTLA) has found new life in premarket trading after Cathie Wood’s Ark Invest disclosed a purchase of more than 560,000 shares.
The move comes at a critical moment: the CRISPR gene-editing specialist is restructuring operations, cutting 27% of staff, and prioritizing late-stage assets, including its treatment for hereditary angioedema (HAE), which could see FDA filing next year.
Shares have been crushed, down 57% over the past 12 months and trading at less than half of their 52-week high. Yet Intellia’s Q2 results offered a glimmer of hope. Collaboration revenue jumped 105% year over year to $14.3 million, thanks in part to its partnership with Regeneron.
Operating losses narrowed sharply, with net loss per share falling from $1.52 to $0.98. With $630 million in cash, management believes it can fund operations through 2027, giving investors some breathing room.
The bigger story is potential. Intellia’s in vivo programs, which deliver CRISPR directly into the body, aim to treat severe genetic conditions with a single intervention. Analysts remain optimistic, with 19 of 28 rating the stock a Strong Buy and consensus targets above $30, implying triple-digit upside.
Ark’s entry reinforces the contrarian bull case, that this beaten-down biotech could rebound if pipeline catalysts deliver. For investors willing to take on volatility, NTLA’s setup offers both risk and unusually high reward potential.
Poll: If recessions had a mascot, what would it be?
Movers and Shakers
American Eagle Outfitters [AEO] – Last Close: $12.85
American Eagle is a specialty apparel retailer best known for its denim, casualwear, and Aerie brand. The stock is sliding nearly 5% in premarket after a stretch of weak results and margin pressure, but analysts are pointing to valuation as the real story. AEO currently trades at a steep discount to peers, with a P/E near 13 and a nearly 4% dividend yield, which is catching attention from value investors.
Despite consumer headwinds, management has leaned into buybacks, repurchasing over 25 million shares since 2024. That confidence could cushion downside while investors wait for a rebound in discretionary spending.
My Take: AEO may stay choppy in the short term, but this looks like one of those classic “buy on weakness” setups. If consumer trends stabilize into the holiday season, today’s discount could pay off.
Venture Global [VG] – Last Close: $12.86
Venture Global is up 4% in premarket trading after UBS upgraded the stock to Buy with an $18 target. Analysts cited stronger-than-expected LNG volumes from the Plaquemines project, which already outpaced its sister facility Calcasieu Pass in Q2. With LNG demand rising globally, UBS estimates an additional $970 million in earnings upside not reflected in current forecasts.
Despite operational progress, Venture Global trades at a discount to peers, leaving room for re-rating as execution continues. The company also eased investor concerns around arbitration risk, adding further confidence in its outlook.
My Take: Strong LNG shipments plus a valuation gap make VG a compelling recovery story. Worth watching if momentum holds.
Wayfair [W] – Last Close: $77.84
Wayfair shares are down almost 5% premarket after President Trump threatened tariffs on imported furniture. The company, which relies heavily on overseas suppliers, would face margin pressure if duties materialize. However, given Trump’s shifting tariff stances, the market reaction may be more noise than signal. Shares remain up nearly 70% this year, supported by improved logistics and resilient home goods demand.
The next 50 days of the tariff probe will be critical. If the investigation stalls or softens, Wayfair could see a relief rally. Short-term volatility may mask the longer-term improvements in its operating model.
My Take: The tariff threat is real but not final. Wayfair’s pullback could be an entry point if duties fail to materialize.
Hidden Picks (Sponsored)
How would it feel to double your money by this time next year?
From thousands of stocks, only 5 have emerged with the best chance to gain +100% or more in the months ahead.
You can see all five of these tickers — absolutely free.
Just download the newly released 5 Stocks Set to Double special report from Zacks.
While we can’t guarantee future performance, previous editions of this report have delivered gains of +175%, +498%, and even +673¹.
The newest picks could be just as profitable.
Act fast — this opportunity ends at MIDNIGHT TONIGHT.
Download the report now, absolutely free
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
Everything Else
Keurig Dr Pepper is buying JDE Peet’s in an $18 billion deal to expand its global coffee reach.
Ørsted shares tumble after the U.S. halted construction on one of its offshore wind projects.
The Federal Reserve is poised to cut rates in September, with the long pause boosting equity market optimism.
SpaceX postponed its latest Starship test flight after a ground system issue delayed launch.
Coca-Cola is exploring a potential sale of Costa Coffee as it reassesses its global beverage portfolio.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
